Beximco Pharmaceuticals Limited reported impressive financial results for the first nine months (July-March) of the current fiscal year 2023-24. According to the company’s unaudited financial statement, its revenue grew by over 13% year-on-year, reaching Tk 3,305 crore, up from Tk 2,923 crore in the same period of the previous year. The company’s net profit also saw a significant jump of 23% during this period. Beximco Pharmaceuticals posted a net profit of Tk 437 crore in the July-March period, with earnings per share (EPS) standing at Tk 9.75. The strong revenue growth and robust net profit figures highlight Beximco Pharmaceuticals’ resilience and ability to navigate the challenging economic landscape. The company’s financial performance underscores its position as a leading player in the pharmaceutical industry in Bangladesh.
BIZDATAINSIGHTS
Bizdata Insights is a Market Insights, Data Intelligence and Business Advisory Platform
Our Solutions
Menu
Newsletter
Sign up for our newsletter now by entering your e-mail address and never miss out on the latest news and updates from our team!